2017 Volume 37 Issue 2 Pages 189-192
Fluorescein, a fluorescent dye, has recently begun to be used in craniotomy to improve the tumor resection rate and avoid neurological complications.
Errors of CO-oximetry occurred in 3 patients after fluorescein administration.
Three patients were administered fluorescein at 1,000 mg intravenously. After administration, measurement of CO-oximetry using RapidPoint 405TM(SIEMENS)including the hemoglobin concentration became impossible.
The errors are believed to have occurred as the measurement wavelength of CO-oximetry was near the wavelength of the absorption peak of fluorescein.